A p105-based Inhibitor Broadly Represses NF-κB Activities
Open Access
- 1 March 2004
- journal article
- Published by Elsevier BV
- Vol. 279 (13), 12819-12826
- https://doi.org/10.1074/jbc.m312572200
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- NF-κB in cancer: a marked targetSeminars in Cancer Biology, 2003
- Rel/NF-κB/IκB signal transduction in the generation and treatment of human cancerCancer Letters, 2002
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- Duration of Nuclear NF-κB Action Regulated by Reversible AcetylationScience, 2001
- Aberrant rel/nfkb genes and activity in human cancerOncogene, 1999
- Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κBNature Medicine, 1999
- TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κBScience, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- NF-κB Controls Expression of Inhibitor IκBα: Evidence for an Inducible Autoregulatory PathwayScience, 1993